Fact based stock research
Akzo Nobel (ENXTAM:AKZA)


Akzo Nobel stock research in summary

akzonobel.com


Akzo Nobel shares have a SELL rating. They are bad value, are riskily financed, and show below average growth. We recommend selling Akzo Nobel shares.


Latest Obermatt Ranks


Country Netherlands
Industry Specialty Chemicals
Index AEX
Size class XX-Large

June 8, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()




Research History: Akzo Nobel

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
68
63
56
49
STOCK GROWTH RANKS
80
38
8
4
STOCK SAFETY RANKS
38
31
57
28
COMBINED STOCK RANKS
74
33
26
4

Last update of Combined Rank: 8-Jun-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Akzo Nobel in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Jun-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Akzo Nobel; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
66
20
2
1
PROFIT GROWTH
50
50
50
8
STOCK RETURNS
67
38
62
39
CONSOLIDATED RANK: GROWTH
80
38
8
4

Financial reporting date of Growth Rank: 31-Mar-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Akzo Nobel.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
51
40
46
31
REFINANCING
4
10
14
52
LIQUIDITY
65
62
52
28
CONSOLIDATED RANK: SAFETY
38
31
57
28

Financial reporting date of Safety Rank: 31-Mar-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Akzo Nobel and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Akzo Nobel from June 8, 2018.